GeneDx Holdings Corp. has grown revenue 24% a year over three years and 16% a year over five. Revenue growth, 3-year annual rate: +24% (Diagnostics & Research median +8.4%). Revenue growth, 5-year rate: +16%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

WGSGeneDx Holdings Corp.

Healthcare

$67.31-48% 1Y

$67.31

$34.5152 weeks$167.51

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +25% year on year, but operating margin narrowing (−22.1 points).

1 good, 1 to watch, 1 without data

Revenue trend+25% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +16% a year.

Margin direction−22.1 points operating

Trailing-twelve-month operating margin, -21.5% now against 0.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is WGS growing?

GeneDx Holdings Corp. has grown revenue 24% a year over three years and 16% a year over five.

+24%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +16%
Revenue growth, 5-year rate · +24% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›